Author | Abhinav Deol, MD | OncLive

Author | Abhinav Deol, MD


Dr. Deol on the FDA Approval of Eltrombopag in Severe Aplastic Anemia

November 17, 2018


Abhinav Deol, MD, associate professor, Karmanos Cancer Institute, discusses the expanded FDA approval of eltrombopag (Promacta) in combination with standard immunosuppressive therapy for the treatment of newly diagnosed adult and pediatric patients 2 years and older with severe aplastic anemia.

Dr. Deol on the Safety of CAR T-Cell Therapy

September 28, 2018


Abhinav Deol, MD, associate professor with Karmanos Cancer Institute, discusses patient eligibility for chimeric antigen receptor (CAR) T-cell therapy in hematologic oncology.